tiprankstipranks
Trending News
More News >
Endo Manufacturing Co., Ltd. (JP:7841)
:7841
Japanese Market
Advertisement

Endo Manufacturing Co., Ltd. (7841) AI Stock Analysis

Compare
0 Followers

Top Page

JP:7841

Endo Manufacturing Co., Ltd.

(7841)

Select Model
Select Model
Select Model
Outperform 80 (OpenAI - 4o)
Rating:80Outperform
Price Target:
¥1,457.00
▲(15.09% Upside)
Endo Manufacturing Co., Ltd. scores well due to its strong financial performance and reasonable valuation. Technical analysis supports a positive outlook, though not overwhelmingly bullish. The absence of earnings call and corporate events data does not detract from the overall positive assessment.

Endo Manufacturing Co., Ltd. (7841) vs. iShares MSCI Japan ETF (EWJ)

Endo Manufacturing Co., Ltd. Business Overview & Revenue Model

Company DescriptionEndo Manufacturing Co., Ltd., together with its subsidiaries, manufactures and sells golf club heads, metal sleeve products, forged components, and medical devices in Japan and internationally. The company offers golf club heads under the Epon Golf brand; and medical devices, including hip joint, femoral head, femoral cup, trauma plate, tibial tray, and knee and femur components. It also provides metal sleeves, such as metal tubes, high precision ultra-thin pipes, heat pipes, bellows base materials, and IH parts for medical parts, automobile parts, and the new energy-related sector; and forged parts, such as engine and transmission gears for automobiles and motorcycles, as well as agricultural machinery parts and others. The company was incorporated in 1950 and is headquartered in Tsubame, Japan.
How the Company Makes MoneyEndo Manufacturing Co., Ltd. generates revenue through multiple streams primarily focused on the sale of its core electronic components and systems. The company's revenue model is largely based on direct sales to manufacturers and distributors in the industrial automation and consumer electronics sectors. Key revenue streams include the sale of proprietary sensors and control systems, which are essential for automation processes in various industries. Additionally, Endo Manufacturing benefits from long-term contracts and partnerships with key industry players, providing them with a stable source of income. The company's investment in research and development enables it to innovate continuously, thereby attracting new clients and retaining existing ones, which further contributes to its earnings.

Endo Manufacturing Co., Ltd. Financial Statement Overview

Summary
Endo Manufacturing Co., Ltd. demonstrates robust financial health with strong revenue growth, solid profit margins, and a stable balance sheet with low leverage. Challenges include a dip in gross profit and decreased operating cash flow, but overall financial stability is strong.
Income Statement
85
Very Positive
Endo Manufacturing Co., Ltd. has shown strong revenue growth with a consistent upward trajectory from 2020 to 2024, notably a 10.88% increase from 2023 to 2024. The gross profit margin has remained healthy, and the net profit margin has improved significantly to 6.42% in 2024 from 4.86% in 2023. Both EBIT and EBITDA margins are robust, indicating efficient operations. However, the dip in gross profit in 2024 suggests some cost management challenges.
Balance Sheet
88
Very Positive
The company exhibits a strong balance sheet with a high equity ratio of 83.86% in 2024, reflecting financial stability and low reliance on debt. The debt-to-equity ratio is impressively low at 0.0079, minimizing financial risk. Return on equity has improved to 5.03%, indicating better utilization of equity to generate profits, though it could be higher for optimal performance.
Cash Flow
78
Positive
Endo Manufacturing's cash flow management is sound, with positive free cash flow indicating efficient capital expenditure control. However, the operating cash flow has decreased in 2024 compared to 2023, which may indicate rising operational costs or reduced cash conversion efficiency. The free cash flow to net income ratio remains positive, underscoring strong cash generation relative to earnings.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue18.04B17.42B15.71B14.58B12.59B8.28B
Gross Profit3.38B3.48B2.76B3.73B3.56B1.45B
EBITDA2.68B2.72B2.16B2.82B2.74B979.74M
Net Income944.92M1.12B762.90M796.80M1.60B-88.10M
Balance Sheet
Total Assets26.61B26.48B24.02B21.87B20.48B17.96B
Cash, Cash Equivalents and Short-Term Investments8.51B9.86B9.04B7.26B6.83B6.44B
Total Debt147.75M175.00M275.00M375.00M1.07B700.00M
Total Liabilities4.67B4.28B4.05B3.50B3.74B2.72B
Stockholders Equity21.94B22.20B19.97B18.37B16.73B15.24B
Cash Flow
Free Cash Flow0.00354.93M1.58B889.84M709.06M-73.95M
Operating Cash Flow0.001.76B2.40B1.93B1.58B599.62M
Investing Cash Flow0.00-1.31B-606.68M-1.03B-1.41B-828.27M
Financing Cash Flow0.00-287.29M-298.36M-868.55M231.35M-260.00M

Endo Manufacturing Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1266.00
Price Trends
50DMA
1260.58
Negative
100DMA
1193.95
Negative
200DMA
1209.19
Negative
Market Momentum
MACD
-19.15
Positive
RSI
29.80
Positive
STOCH
24.58
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7841, the sentiment is Negative. The current price of 1266 is above the 20-day moving average (MA) of 1247.50, above the 50-day MA of 1260.58, and above the 200-day MA of 1209.19, indicating a bearish trend. The MACD of -19.15 indicates Positive momentum. The RSI at 29.80 is Positive, neither overbought nor oversold. The STOCH value of 24.58 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7841.

Endo Manufacturing Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
¥10.48B13.683.37%3.14%-40.34%
78
Outperform
¥8.87B3.123.97%7.24%216.11%
75
Outperform
¥3.98B20.504.89%-11.24%-48.52%
70
Outperform
¥13.89B12.122.47%0.75%-2.08%
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:7841
Endo Manufacturing Co., Ltd.
1,177.00
-39.97
-3.28%
JP:7608
SK Japan Co., Ltd.
1,343.00
710.04
112.18%
JP:7809
KOTOBUKIYA CO., LTD.
1,640.00
96.36
6.24%
JP:7847
Graphite Design Inc.
615.00
-118.61
-16.17%
JP:7865
People Co., Ltd.
441.00
-167.00
-27.47%
JP:8135
ZETT CORP.
457.00
101.83
28.67%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 23, 2025